Novalis II General Partner BV

Ottergemsesteenweg-Zuid 808 Bus B511

9000 Gent

BE

Novalis II General Partner BV

Foundation date

21/08/2017

Sector

#Investor

Subsector

Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.

Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.

Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.

As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.

Latest news

  • P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services

    Thursday September 5th 2024

  • reMYND appoints new CEO and Chairman to progress novel Alzheimer’s Disease program through clinical development

    Tuesday September 3rd 2024

  • Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

    Monday September 2nd 2024